Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: Potential implications for tissue engineering of tendons and ligaments

被引:162
|
作者
Hankemeier, S [1 ]
Keus, M [1 ]
Zeichen, J [1 ]
Jagodzinski, M [1 ]
Barkhausen, T [1 ]
Bosch, U [1 ]
Krettek, C [1 ]
Van Griensven, M [1 ]
机构
[1] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany
来源
TISSUE ENGINEERING | 2005年 / 11卷 / 1-2期
关键词
D O I
10.1089/ten.2005.11.41
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bone marrow stromal cells (BMSCs) play a central role in the repair and regeneration of mesenchymal tissues. For tissue engineering of ligaments and tendons, both stimulation of cell proliferation and differentiation with increased expression of essential extracellular matrix proteins and cytoskeletal elements are desirable. This study analyzes the effect of low-dose ( 3 ng/mL) fibroblast growth factor 2 (FGF-2) and high-dose FGF-2 ( 30 ng/mL) on proliferation ( bromodeoxyuridine content, spectrophotometry), differentiation ( transcription of collagen I, collagen III, fibronectin, elastin, alpha-smooth muscle actin, and vimentin, reverse transcription- polymerase chain reaction, and cell density and apoptosis ( annexin V, fluorescence-activated cell sorting) of human BMSCs, and compares the results with those of a control group without FGF-2. Low-dose FGF-2 triggered a biphasic BMSC response: on day 7, cell proliferation reached its maximum and was significantly higher compared with the other groups. On days 14 or 28, collagen I, collagen III, fibronectin, and alpha-smooth muscle actin mRNA expression was significantly enhanced in the presence of low-dose FGF-2. In contrast, high-dose FGF-2 did not stimulate differentiation or proliferation. Vimentin mRNA was expressed only in cultures with low-dose and high-dose FGF-2 after 14 and 28 days. Cell density was significantly higher in cultures with low-dose FGF-2 compared with the group with high-dose FGF-2 on days 7, 14, and 28. The apoptosis rate remained stable, at a rather high level, in all groups. Microscopic investigation of the cell cultures with low-dose FGF-2 showed more homogeneous, dense, fibroblast-like, spindle-shaped cells with long cell processes compared with cultures with high-dose, or no FGF-2. Low-dose FGF-2 may be useful for tissue engineering of ligaments and tendons by increasing BMSC proliferation and stimulating mRNA expression of specific extracellular matrix proteins and cytoskeletal elements.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 50 条
  • [1] Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering
    Narine, Kishan
    De Wever, Olivier
    Van Valckenborgh, Dillis
    Francois, Katrien
    Bracke, Marc
    Desmet, Stefaan
    Mareel, Marc
    Van Nooten, Guido
    TISSUE ENGINEERING, 2006, 12 (10): : 2707 - 2716
  • [2] Basic fibroblast growth factor regulates proliferation and differentiation in rat bone marrow stromal cells.
    Tanaka, H
    Liang, CT
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M315 - M315
  • [3] Growth factor induced fibroblast differentiation from human bone marrow stromal cells in vitro
    Moreau, JE
    Chen, JS
    Bramono, DS
    Volloch, V
    Chernoff, H
    Vunjak-Novakovic, G
    Richmond, JC
    Kaplan, DL
    Altman, GH
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2005, 23 (01) : 164 - 174
  • [4] Effect of culture substrates and fibroblast growth factor addition on the proliferation and differentiation of rat bone marrow stromal cells
    Hori, Y
    Inoue, S
    Hirano, Y
    Tabata, Y
    TISSUE ENGINEERING, 2004, 10 (7-8): : 995 - 1005
  • [5] Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: Results of a histologic study
    Stefan Hankemeier
    Martijn van Griensven
    Marco Ezechieli
    Tanja Barkhausen
    Matthew Austin
    Michael Jagodzinski
    Rupert Meller
    Ulrich Bosch
    Christian Krettek
    Johannes Zeichen
    Archives of Orthopaedic and Trauma Surgery, 2007, 127 : 815 - 821
  • [6] Epidermal growth factor (EGF) transfection of human bone marrow stromal cells in bone tissue engineering
    Wallmichrath, J.
    Stark, G. B.
    Kneser, U.
    Andree, C.
    Voigt, M.
    Horch, R. E.
    Schaefer, D. J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) : 2593 - 2601
  • [7] Tissue engineering of tendons and ligaments by human bone marrow stromal cells in a liquid fibrin matrix in immunodeficient rats: Results of a histologic study
    Hankemeier, Stefan
    van Griensven, Martijn
    Ezechieli, Marco
    Barkhausen, Tanja
    Austin, Matthew
    Jagodzinski, Michael
    Meller, Rupert
    Bosch, Ulrich
    Krettek, Christian
    Zeichen, Johannes
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2007, 127 (09) : 815 - 821
  • [8] Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: A whole cell model
    Dupree, Melissa A.
    Pollack, Solomon R.
    Levine, Elliot M.
    Laurencinz, Cato T.
    BIOPHYSICAL JOURNAL, 2006, 91 (08) : 3097 - 3112
  • [9] Effects of pH on human bone marrow stromal cells in vitro:: Implications for tissue engineering of bone
    Kohn, DH
    Sarmadi, M
    Helman, JI
    Krebsbach, PH
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 60 (02): : 292 - 299
  • [10] Enhancing proliferation and optimizing the culture condition for human bone marrow stromal cells using hypoxia and fibroblast growth factor-2
    Lee, Jung-Seok
    Kim, Seul Ki
    Jung, Byung-Joo
    Choi, Seong-Bok
    Choi, Eun-Young
    Kim, Chang-Sung
    STEM CELL RESEARCH, 2018, 28 : 87 - 95